Vista Pharmaceuticals (BOM:524711) Inventories, Raw Materials & Components: ₹0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524711 Vista Pharmaceuticals Ltd BOM:524711
47 GF Score
Price ₹7.08
GF Value ₹6.08
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Vista Pharmaceuticals Inventories, Raw Materials & Components?

Vista Pharmaceuticals BOM:524711 -5.35% 47 Inventories, Raw Materials & Components is ₹0.00 Mil as of Mar. 2026. GuruFocus rates BOM:524711 with a GF Score™ of 47/100 and a GF Value™ of ₹6.08 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Vista Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Mar. 2026 was ₹0.00 Mil.

Vista Pharmaceuticals's annual raw materials increased from Mar. 2024 (₹2.24 Mil) to Mar. 2025 (₹29.59 Mil) but then declined from Mar. 2025 (₹29.59 Mil) to Mar. 2026 (₹0.00 Mil).

Vista Pharmaceuticals Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Vista Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vista Pharmaceuticals Inventories, Raw Materials & Components Chart

Vista Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.99 5.06 2.24 29.59 0.00

Vista Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.59 0.00 0.00 0.00 0.00
BOM:524711
47GF Score
Vista Pharmaceuticals Ltd BOM:524711
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vista Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₹0.00 Mil mean?
Vista Pharmaceuticals (BOM:524711) has a Inventories, Raw Materials & Components of ₹0.00 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Vista Pharmaceuticals and its competitors.
Is Vista Pharmaceuticals' Inventories, Raw Materials & Components too high?
Vista Pharmaceuticals' current Inventories, Raw Materials & Components is ₹0.00 Mil. Overall, Vista Pharmaceuticals has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vista Pharmaceuticals' Inventories, Raw Materials & Components compare to ZTS and UTHR?
Vista Pharmaceuticals' Inventories, Raw Materials & Components of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Vista Pharmaceuticals and its competitors. Vista Pharmaceuticals's current Inventories, Raw Materials & Components is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vista Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Vista Pharmaceuticals (BOM:524711) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6.08, compared to a current price of ₹7.08 — trading 16.4% above its estimated fair value. The current Inventories, Raw Materials & Components is ₹0.00 Mil. Vista Pharmaceuticals' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Vista Pharmaceuticals (BOM:524711), the current Inventories, Raw Materials & Components is ₹0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vista Pharmaceuticals (BOM:524711) Overvalued in 2026?

Based on GuruFocus' analysis, Vista Pharmaceuticals stock appears to be overvalued. The current stock price of ₹7.08 is trading 16.4% above its estimated GF Value™ of ₹6.08. GuruFocus considers Vista Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BOM:524711:

  • Inventories, Raw Materials & Components: ₹0.00 Mil
  • GF Value™: ₹6.08 vs. price of ₹7.08 (16.4% above fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:524711 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vista Pharmaceuticals Business Description

Address Kakateeya Hills, Plot No. 104, Ravindra Co Operative Society, Guttala Begumpet, Hyderabad, TG, IND, 500033
Vista Pharmaceuticals Ltd is an Indian company engaged in a single operating segment, which is the manufacturing of Pharmaceutical products. The company offers over-the-counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, and Indomethacin are the drugs offered by the company in a capsule dosage form. The company generates all of its operating revenue from sales within its domestic market.
47GF Score

Get the complete analysis for BOM:524711

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.08
Price
₹6.08
GF Value